Alexander Gaffney (Regulatory Focus / RAPS)
Scientific method: Statistical errors...P values, the 'gold standard' of statistical validity, are not as reliable as many scientists assume.
Regina Nuzzo (Nature)
It's a Slippery Slope. Get Over It.
Laura Hercher (The DNA Exchange)
Drug firms lifted by 'fast medicines' deal: Pharmaceutical sector to welcome Government plans which could see patients may get treatments up to 10 years earlier
Denise Roland (The Telegraph [U.K.])
So many unanswered questions, but a story worth following. Comparisons (and contrasts) will naturally be made vs. US FDA Breakthrough Therapy designation.
The Fat Drug
Pagan Kennedy (New York Times)
Public Resources on the FDA.gov website - I highlighted my 5 favorite sections of the FDA website that provide access to public information that can be extremely valuable to the biotech investor or enthusiast.